Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guinn, T. S.
Right arrow Articles by Mecklenburg, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guinn, T. S.
Right arrow Articles by Mecklenburg, R. S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 11, Issue 1 46-51, Copyright © 1988 by American Diabetes Association


ARTICLES

Factors related to discontinuation of continuous subcutaneous insulin-infusion therapy

TS Guinn, GJ Bailey and RS Mecklenburg
Section of Endocrinology and Diabetes, Virginia Mason Clinic, Seattle, WA 98111.

To determine the factors related to discontinuation of continuous subcutaneous insulin-infusion (CSII) therapy in patients with insulin-dependent diabetes mellitus, we analyzed clinical data from a group of 177 patients followed for up to 5 yr. Fifty-one (29%) of the patients made a decision to terminate CSII during the study. Of the clinical characteristics present before the onset of treatment with an insulin pump, the most important variable to predict a future decision to terminate CSII was pregnancy, followed by female gender. In addition, there was a greater percentage of smokers, single or divorced patients, and patients with a history of treatment for mental illness in the dropout group, although none of these differences was statistically significant. There was no correlation between discontinuation of CSII and age, duration of diabetes, or prepump concentrations of HbA1c. Events occurring during CSII were also analyzed for predictive value. Patients who discontinued CSII had a higher incidence of ketoacidosis and a lower incidence of hypoglycemic coma while using a pump. The most common reason reported by patients for terminating CSII therapy, cited by 24 (47%) of the 51, was discomfort, irritation, or infection at the infusion site.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
J. Weissberg-Benchell, J. Antisdel-Lomaglio, and R. Seshadri
Insulin Pump Therapy: A meta-analysis
Diabetes Care, April 1, 2003; 26(4): 1079 - 1087.
[Abstract] [Full Text] [PDF]


Home page
The Diabetes EducatorHome page
J. A. Sanfield, M. Hegstad, and R. S. Hanna
Protocol for Outpatient Screening and Initiation of Continuous Subcutaneous Insulin Infusion Therapy: Impact on Cost and Quality
The Diabetes Educator, July 1, 2002; 28(4): 599 - 607.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
M. J. Lenhard and G. D. Reeves
Continuous Subcutaneous Insulin Infusion: A Comprehensive Review of Insulin Pump Therapy
Arch Intern Med, October 22, 2001; 161(19): 2293 - 2300.
[Abstract] [Full Text] [PDF]


Home page
The Diabetes EducatorHome page
R. S. Mecklenburg
Acute Complications Associated With the Use of Insulin Infusion Pumps
The Diabetes Educator, January 1, 1989; 15(1): 40 - 43.
[PDF]


Home page
The Diabetes EducatorHome page
D. L. Jornsay, A. E. Duckles, and J. P. Hankinson
Psychological Considerations for Patient Selection and Adjustment to Insulin Pump Therapy
The Diabetes Educator, January 1, 1988; 14(4): 291 - 296.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1988 by the American Diabetes Association.